Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
SIGACHI.NS
HoldHot AirSigachi Industries Limited · Healthcare · India · $140M · Avg Vol: $1M/d
39
StockRankGet insider-trade alerts
Q
36
V
29
M
67
P/E (TTM)
52.6x
ROE
-15.7%
D/E
0.3x
Dividend %
0.3%
COMPANY DESCRIPTION
Sigachi Industries Limited manufactures and sells microcrystalline cellulose and cellulose powder in India.
FINANCIAL SUMMARY (INR)
| Year | 2023 | 2024 | 2025 | 2026 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 3.0B | 4.0B | 4.9B | 4.8B | 16.5% | 4.7B |
| EPS (INR) | 1.42 | 1.81 | 2.06 | -2.14 | 20.4% | 0.67 |
| Shares | 307.4M | 328.2M | 382.1M | 382.1M | +24.3% | 382.1M |
| Debt | 684.8M | 1.5B | 1.4B | 1.6B | 33.3% | 1.6B |
| Equity | 2.7B | 4.3B | 6.0B | 5.2B | 24.8% | — |
| Op CF | 290.2M | 128.9M | 269.3M | -428.0M | -3.7% | -428.0M |
| Inv CF | -918.5M | -1.6B | -930.7M | -54.5M | — | — |
| Fin CF | 262.1M | 1.7B | 811.0M | 22.4M | — | — |
Loading 1Y...
PRICE (1Y)+36.0%
SMA 50SMA 200
Close
$0.3709
RSI (14)
75.3
52W High
$0.4902
From 52W High
0.8%
SCORE BREAKDOWN
Quality
36
ROIC
-13.1%33.0
ROE
-15.7%31.9
GP/Assets
27.1%58.0
Op. Margin
10.0%62.4
FCF/Assets
-10.4%29.0
Piotroski
25.9
Int. Cover
-5.9x26.1
D/E Ratio
0.31x40.5
Current Ratio
1.44x24.8
Value
29
P/E (TTM)
52.6x20.7
EV/EBITDA
30.2x21.0
P/FCF
—N/A
P/B
2.6x52.1
P/S
2.9x58.2
Div Yield
0.3%7.8
Momentum
67
52W High %
76%58.0
RS 6M
92%96.1
SMA 50/200
1.09x73.7
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$140M
P/E (Forward)
—
Gross Margin
48.5%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of SIGACHI.NS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| SIGACHI.NS | Sigachi Industries Limited(you) | $140M | 39 | Hold |
| SHUKRAPHAR.NS | Shukra Pharmaceuticals Limited | $252M | 38 | Hold |
| AMRUTANJAN.NS | Amrutanjan Health Care Limited | $153M | 53 | Hold |
| BAJAJHCARE.NS | Bajaj HealthCare Limited | $120M | 59 | Hold |
| THEMISMED.NS | Themis Medicare Limited | $129M | 62 | Hold |
| SGRL.NS | Shree Ganesh Remedies Limited | $94M | 21 | Sell |
| BAFNAPH.NS | Bafna Pharmaceuticals Limited | $77M | 55 | Hold |
| INDOCO.NS | Indoco Remedies Limited | $237M | 57 | Hold |
| ORCHPHARMA.NS | Orchid Pharma Limited | $517M | 45 | Hold |
| KILITCH.NS | Kilitch Drugs (India) Limited | $69M | 58 | Hold |
Peer medians: ROE 11.9% · P/E 42.5x · Gross margin 59.4%